Back to search

Clemson University

Advancing Substance Use Disorder Treatment Using Genomics and Metabolomics

Abstract

dc:description.abstract

Advancing our understanding of genetic, metabolic, and environmental factors in substance use disorder (SUD) could lead to more effective therapies. In 2022, 16.5% of the U.S. population was diagnosed with SUD, yet current treatments lack efficacy for all patients, making a precision medicine approach crucial. This dissertation explores SUD's relationship with tryptophan (TRP) metabolism through the kynurenine pathway (KP) as a potential therapeutic target. Chapter I reviews current knowledge on SUD and KP. Chapter II identifies how SUD alters KP metabolite concentrations, identifying a reduced concentration of the neuroprotective metabolite, kynurenic acid (KA) and elevated concentrations of the neurotoxic metabolite, quinolinic acid (QA). Chapter III examines genetic variants in KP enzyme genes, revealing significant differences between SUD and control groups that may predispose individuals to SUD by altering neurotoxic and neuroprotective metabolite levels. Chapter IV describes a validated mass-spectrometry method to quantify TRP metabolites in urine. Clinical analysis showed elevated kynurenine (p = .011) and quinolinic acid (p = .003) in SUD samples, suggesting KP dysregulation in SUD. Future research should combine metabolite quantification with genetic analysis to further identify the genetic impact on KP metabolite imbalances. Chapter V synthesizes findings, limitations, and future directions, for SUD research. Together, these studies reveal KP's potential as a therapeutic target and provide tools for monitoring SUD treatment efficacy, laying the groundwork for precision medicine approaches in SUD treatment.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Healthcare Genetics

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Contella, Lindsey
Contributors dc:contributor
  • Christopher Farrell
  • Luigi Boccuto
  • Alain Litwin
  • Marion Snyder

Subjects

dc:subject × 5

Identifiers

dc:identifier.*
Repository record dc:identifier
https://open.clemson.edu/all_dissertations/3842

Chain of custody

source
Harvested from
Clemson University
Base URL
open.clemson.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Contella, Lindsey. Advancing Substance Use Disorder Treatment Using Genomics and Metabolomics. Dissertation thesis, https://open.clemson.edu/all_dissertations/3842